Head and Neck Sarcoma: Report of the Head and Neck Sarcoma Registry
โ Scribed by Drs Harold J. Wanebo; Drs R. James Koness; Dr. John K. Macfarlane; Dr. Frederick R. Eilber; Dr. Robert M. Byers; Dr. E. George Elias; Dr. Ronald H. Spiro
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 581 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
โฆ Synopsis
A Head and Neck Sarcoma Registry was established by the Society of Head and Neck Surgeons to review treatment results of a rare tumor by surgeons with special interest in this anatomic site. Two hundred fourteen patients were analyzed. There were 194 adult tumors and 20 pediatric tumors. The major sites included parotid and neck, 20%; face and forehead, 18%; maxilla and palate, 13%; scalp, 12%; mandible, 11%; paranasal sinuses, 7%; larynx, 2%; and oral cavity, 5%. Eighty-four percent were resectable. The disease-free survival was 56%; overall survival was 70% at 5 years. Major determinants of suwival were adequacy of resection (margins free of tumor) and tumor type. Survival differed according to tumor cell type (tumor grade was not available). Patients with chondrosarcoma and dermatofibrosarcoma had survival approaching 100%. Patients with malignant fibrous histiocytoma (MFH) and fibrosarcoma (FSA) had intermediate survival of 60% to 70%. The worst survival, < 50% at 5 years, occurred in patients with osteosarcoma, angiosarcoma, and rhabdomyosarcoma in decreasing order. This
๐ SIMILAR VOLUMES
## Abstract Primary synovial sarcoma is an unusual tumor of the head and neck. Fewer than 75 cases have been reported in the literature. We have treated 7 additional cases; 3 in the hypopharynx, 2 in the parapharyngeal space, 1 in the oral pharynx and 1 in the posterior triangle of the neck. An enl
## Background: Head and neck sarcomas are extremely rare. this article reviews the management and outcomes in a multidisciplinary clinic. ## Methods: The records of 41 male and 19 female patients (mean age, 50 years) were reviewed. forty percent underwent surgical resection only, 35% underwent su
Background. Radiation-induced sarcoma of the head and neck (RISHN) is a long-term complication of treatment. The rarity of this tumour is reflected in the very few series reported in the English language medical literature. The incidence of RISHN is, however, likely to increase due to progressive ag